The use of current knowledge and non‐invasive testing modalities for predicting at‐risk non‐alcoholic steatohepatitis and assessing fibrosis
出版年份 2023 全文链接
标题
The use of current knowledge and non‐invasive testing modalities for predicting at‐risk non‐alcoholic steatohepatitis and assessing fibrosis
作者
关键词
-
出版物
LIVER INTERNATIONAL
Volume 43, Issue 5, Pages 964-974
出版商
Wiley
发表日期
2023-03-03
DOI
10.1111/liv.15555
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A sequential approach using the age‐adjusted fibrosis‐4 index and vibration‐controlled transient elastography to detect advanced fibrosis in Korean patients with non‐alcoholic fatty liver disease
- (2022) Dong Hyeon Lee et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events
- (2022) Jerome Boursier et al. JOURNAL OF HEPATOLOGY
- American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
- (2022) Kenneth Cusi et al. Endocrine Practice
- Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease?
- (2022) Zobair M. Younossi et al. HEPATOLOGY
- Greater ectopic fat deposition and liver fibroinflammation, and lower skeletal muscle mass in people with type 2 diabetes
- (2022) Tom Waddell et al. Obesity
- AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review
- (2022) Michelle T. Long et al. GASTROENTEROLOGY
- Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants
- (2022) Veeral Ajmera et al. GASTROENTEROLOGY
- Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort
- (2021) Kento Imajo et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis
- (2021) Andrea Dennis et al. Frontiers in Endocrinology
- Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort
- (2021) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-Analysis
- (2021) Helena B. Thomaides-Brears et al. DIGESTIVE DISEASES AND SCIENCES
- Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
- (2021) Fasiha Kanwal et al. GASTROENTEROLOGY
- Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity
- (2021) Andreas Drolz et al. INTERNATIONAL JOURNAL OF OBESITY
- EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update
- (2021) Annalisa Berzigotti et al. JOURNAL OF HEPATOLOGY
- Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease
- (2021) Zobair M. Younossi et al. JAMA Network Open
- Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis
- (2021) Anneli Andersson et al. Clinical Gastroenterology and Hepatology
- Comparison of diagnostic performance between FIB‐4 and NFS in metabolic‐associated fatty liver disease era
- (2021) Huiyul Park et al. HEPATOLOGY RESEARCH
- MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis
- (2021) Mazen Noureddin et al. JOURNAL OF HEPATOLOGY
- Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
- (2021) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease
- (2020) Tasnim Alkayyali et al. ACTA DIABETOLOGICA
- FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
- (2020) Philip N Newsome et al. Lancet Gastroenterology & Hepatology
- Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease
- (2020) Amandeep Singh et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices
- (2020) Zobair M. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood‐based fibrosis markers in patients with chronic liver disease
- (2020) Arjun N.A. Jayaswal et al. LIVER INTERNATIONAL
- MR elastography‐based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study
- (2020) Ma Ai Thanda Han et al. LIVER INTERNATIONAL
- A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
- (2020) Stephen A Harrison et al. Lancet Gastroenterology & Hepatology
- Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation and Death in NAFLD
- (2020) Tolga Gidener et al. Clinical Gastroenterology and Hepatology
- Accuracy of Fibrosis-4 index and non-alcoholic fatty liver disease fibrosis scores in metabolic (dysfunction) associated fatty liver disease according to body mass index
- (2020) Fatih Eren et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes
- (2020) Zobair M. Younossi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
- (2019) Arun J. Sanyal et al. HEPATOLOGY
- Past, present and future perspectives in nonalcoholic fatty liver disease
- (2019) Arun J. Sanyal Nature Reviews Gastroenterology & Hepatology
- Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease
- (2019) Eda Kaya et al. Gut and Liver
- The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis
- (2019) Fuad Jafarov et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare Patients
- (2019) Stuart Gordon et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances
- (2018) Mazen Noureddin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The enhanced liver fibrosis (ELF) test in diagnosis and management of liver fibrosis
- (2018) James W Day et al. BRITISH JOURNAL OF HOSPITAL MEDICINE
- The role of 3D-MRE in the diagnosis of NASH in obese patients undergoing bariatric surgery
- (2018) Alina M. Allen et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- (2017) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity
- (2017) Michael Pavlides et al. LIVER INTERNATIONAL
- Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage
- (2017) Mario Masarone et al. PLoS One
- Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
- (2016) Stuart McPherson et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort
- (2016) Veronica Wendy Setiawan et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Decision analytic model of the diagnostic pathways for patients with suspected non-alcoholic fatty liver disease using non-invasive transient elastography and multiparametric magnetic resonance imaging
- (2016) Laurence Blake et al. BMJ Open
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma
- (2015) Mazen Noureddin et al. Clinics in Liver Disease
- Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
- (2015) Robert J. Wong et al. GASTROENTEROLOGY
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis
- (2015) Bashar Mohamad et al. Hepatology International
- Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD
- (2012) Z. Permutt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality
- (2011) Zobair M. Younossi et al. HEPATOLOGY
- T1 independent, T2* corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis
- (2011) Catherine D.G. Hines et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started